IHE

iShares U.S. Pharmaceuticals ETF
CLOSING PRICECHANGE (%)VOLUME
$159.71-0.05 (-0.03%)6.76K
3:59:00 p.m. (ET) 06/23/2017
BZX EXCHANGE CLOSED
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------
A

52
  • Overview
  • Efficiency
  • Tradability
  • Fit

IHE Fund Description

The iShares Dow Jones U.S. Pharmaceuticals ETF tracks a broad-based, cap-weighted index of US pharmaceutical companies.

IHE FactSet Analytics Insight

IHE provides comprehensive but skewed coverage of pharmaceuticals, holding about 40 of the largest US pharmaceutical names, and capping large holdings in an industry where three players (J&J, Pfizer and Merck) take up more than 40% of the market cap. This heavily tilts IHE toward mid- and small-caps compared to our benchmark. While pharmaceuticals account for a hefty majority of IHE, the fund also holds positions in biotech. Its departures from neutral exposure seem to have resulted in a fund with greater volatility than the market it's trying to capture. IHE sees inconsistent trading volume, and retail investors should be wary of considerable spreads, though underlying liquidity is better for large investors. IHE charges a typical fee for its segment, and tracking is roughly in-line with that fee, if not a little better thanks to its securities lending program.

IHE MSCI ESG Fund metrics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of June 22, 2017 the iShares U.S. Pharmaceuticals ETF MSCI ESG Fund Quality Score is 4.49 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. IHE ranks in the 41st percentile within its peer group and in the 20th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

IHE Top 10 Countries

IHE Top 10 Sectors

IHE Top 10 Holdings View All

IHE Summary Data

05/01/06
Open-Ended Fund
0.44%
$724.75 M
$2.18 M
0.20%

IHE Portfolio Data

$81.22 B
-34.46
3.14
0.63%
06/27/17
41

IHE Index Data

Dow Jones U.S. Select Pharmaceuticals Index
Market Cap
Market Cap
Thomson Reuters US Pharmaceuticals

Related ETFs to IHE

FTXH, PJP, XPH
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

IHE Portfolio Management

0.44%
-0.32%
-0.23%
-0.45%

IHE Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

IHE Fund Structure

Open-Ended Fund
No
Yes
70% / 30%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
15:59:34159.9284
15:34:19159.36100
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 23:59:59
Average Spread
Premium/Discount
Volume

IHE FactSet Analytics Block Liquidity

As of 06/23/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IHE. IHE is rated a 5 out of 5.

IHE Tradability

14,401
$2.18 M
10,177
$1.53 M
0.20%
$0.3
-0.02%
0.25% / -0.26%
None
100.00%
50,000
0.20
0.00%
0.47%
68
$159.76
5

IHE Performance Statistics

0.76
1.31
1.24
1.33
0.68%
Thomson Reuters US Pharmaceuticals

IHE MSCI ESG Fund Metrics

4.49 / 10
40.83
19.69
--
3.26%
38.07